Question 1

How will the nurse training work, and what will I learn?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the VIGIP-SEP2: Training of Patients by Nurses on ADR Reporting by RRMS Patient Via an App clinical trial (NCT04116424). Contact the study team or your healthcare provider for specific answers.

Question 2

What kind of follow-up will I receive after the training?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the VIGIP-SEP2: Training of Patients by Nurses on ADR Reporting by RRMS Patient Via an App clinical trial (NCT04116424). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this trial compare to other ways of reporting side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the VIGIP-SEP2: Training of Patients by Nurses on ADR Reporting by RRMS Patient Via an App clinical trial (NCT04116424). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the VIGIP-SEP2: Training of Patients by Nurses on ADR Reporting by RRMS Patient Via an App clinical trial (NCT04116424). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks involved in using the mobile app?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the VIGIP-SEP2: Training of Patients by Nurses on ADR Reporting by RRMS Patient Via an App clinical trial (NCT04116424). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my participation in this trial affect my overall treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the VIGIP-SEP2: Training of Patients by Nurses on ADR Reporting by RRMS Patient Via an App clinical trial (NCT04116424). Contact the study team or your healthcare provider for specific answers.

What this study is about